跳至主要内容
临床试验/IRCT20090526001952N16
IRCT20090526001952N16招募中3 期

Comparison of the effect of two cabergoline administration methods to prevent ovarian hyperstimulation syndrome (OHSS) in patients with polycystic ovary syndrome (PCO) under IVF

Tehran University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Age range of 18 to 45 years old
  • Patients with polycystic ovary syndrome
  • high level of anti-müllerian hormone (AMH) level (> 3 ng/ml) and/or high antral follicle count (AFC)>20

排除标准

  • Allergy to cabergoline
  • Not taking the drug completely
  • Stopping the drug due to side effects or drug sensitivity

研究者

相似试验